NO990322L - Pharmaceutical mixture containing a 5HT2c antagonist and a D2 antagonist - Google Patents
Pharmaceutical mixture containing a 5HT2c antagonist and a D2 antagonistInfo
- Publication number
- NO990322L NO990322L NO990322A NO990322A NO990322L NO 990322 L NO990322 L NO 990322L NO 990322 A NO990322 A NO 990322A NO 990322 A NO990322 A NO 990322A NO 990322 L NO990322 L NO 990322L
- Authority
- NO
- Norway
- Prior art keywords
- antagonist
- 5ht2c
- mixture containing
- pharmaceutical mixture
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Det beskrives kombinasjoner av forbindelser som har 5HT2C- og D2-antagonistvirkning, forbindelser som har aktivitet ved de to reseptorene, farmasøytiske blandinger hvori disse inngår, og deres anvendelse ved behandling av schizofreni.Combinations of compounds having 5HT2C and D2 antagonist activity are described, compounds having activity at the two receptors, pharmaceutical compositions comprising them, and their use in the treatment of schizophrenia.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9615767.2A GB9615767D0 (en) | 1996-07-26 | 1996-07-26 | Novel treatment |
| PCT/EP1997/004159 WO1998004289A2 (en) | 1996-07-26 | 1997-07-22 | Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO990322D0 NO990322D0 (en) | 1999-01-25 |
| NO990322L true NO990322L (en) | 1999-03-24 |
Family
ID=10797573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO990322A NO990322L (en) | 1996-07-26 | 1999-01-25 | Pharmaceutical mixture containing a 5HT2c antagonist and a D2 antagonist |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0936924A2 (en) |
| JP (1) | JP2000516924A (en) |
| KR (1) | KR20000029564A (en) |
| CN (1) | CN1230894A (en) |
| AR (1) | AR008083A1 (en) |
| AU (1) | AU725817B2 (en) |
| BR (1) | BR9710568A (en) |
| CA (1) | CA2261813A1 (en) |
| CO (1) | CO5031292A1 (en) |
| CZ (1) | CZ23799A3 (en) |
| GB (1) | GB9615767D0 (en) |
| HU (1) | HUP9903619A3 (en) |
| IL (1) | IL128219A0 (en) |
| NO (1) | NO990322L (en) |
| NZ (1) | NZ333813A (en) |
| PL (1) | PL331426A1 (en) |
| TR (1) | TR199900140T2 (en) |
| WO (1) | WO1998004289A2 (en) |
| ZA (1) | ZA976593B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9612883D0 (en) * | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
| JP2002530341A (en) | 1998-11-23 | 2002-09-17 | セプラコール， インク． | Desmethylolanzapine compositions and methods |
| JP2002530339A (en) | 1998-11-23 | 2002-09-17 | セプラコール， インク． | 2-Hydroxymethylolanzapine compositions and methods |
| JP2002530340A (en) * | 1998-11-23 | 2002-09-17 | セプラコール， インク． | Pharmaceutical composition containing olanzapine-N-oxide |
| EP1165090A2 (en) * | 1999-03-18 | 2002-01-02 | Children's Hospital Research Foundation | A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications |
| WO2000071106A2 (en) * | 1999-05-19 | 2000-11-30 | Astrazeneca Ab | Method of treating weight gain |
| WO2005013969A1 (en) * | 2003-07-15 | 2005-02-17 | Janssen Pharmaceutica N.V. | Antipsychotic agent with socializing properties |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9500998D0 (en) * | 1995-03-19 | 1995-03-19 | Haakan Wilhelm Wikstroem | New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics |
-
1996
- 1996-07-26 GB GBGB9615767.2A patent/GB9615767D0/en active Pending
-
1997
- 1997-07-22 HU HU9903619A patent/HUP9903619A3/en unknown
- 1997-07-22 BR BR9710568A patent/BR9710568A/en not_active Application Discontinuation
- 1997-07-22 PL PL97331426A patent/PL331426A1/en unknown
- 1997-07-22 EP EP97918947A patent/EP0936924A2/en not_active Ceased
- 1997-07-22 WO PCT/EP1997/004159 patent/WO1998004289A2/en not_active Application Discontinuation
- 1997-07-22 IL IL12821997A patent/IL128219A0/en unknown
- 1997-07-22 CZ CZ99237A patent/CZ23799A3/en unknown
- 1997-07-22 AU AU42972/97A patent/AU725817B2/en not_active Ceased
- 1997-07-22 NZ NZ333813A patent/NZ333813A/en unknown
- 1997-07-22 CN CN97197977A patent/CN1230894A/en active Pending
- 1997-07-22 KR KR1019997000622A patent/KR20000029564A/en not_active Application Discontinuation
- 1997-07-22 TR TR1999/00140T patent/TR199900140T2/en unknown
- 1997-07-22 JP JP10508522A patent/JP2000516924A/en active Pending
- 1997-07-22 CA CA002261813A patent/CA2261813A1/en not_active Abandoned
- 1997-07-24 AR ARP970103348A patent/AR008083A1/en not_active Application Discontinuation
- 1997-07-24 ZA ZA976593A patent/ZA976593B/en unknown
- 1997-07-25 CO CO97042582A patent/CO5031292A1/en unknown
-
1999
- 1999-01-25 NO NO990322A patent/NO990322L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000516924A (en) | 2000-12-19 |
| PL331426A1 (en) | 1999-07-19 |
| AU4297297A (en) | 1998-02-20 |
| GB9615767D0 (en) | 1996-09-04 |
| CN1230894A (en) | 1999-10-06 |
| AR008083A1 (en) | 1999-12-09 |
| HUP9903619A2 (en) | 2000-10-28 |
| HUP9903619A3 (en) | 2001-03-28 |
| NZ333813A (en) | 2000-07-28 |
| EP0936924A2 (en) | 1999-08-25 |
| ZA976593B (en) | 1999-01-25 |
| CZ23799A3 (en) | 1999-06-16 |
| CO5031292A1 (en) | 2001-04-27 |
| KR20000029564A (en) | 2000-05-25 |
| TR199900140T2 (en) | 1999-03-22 |
| NO990322D0 (en) | 1999-01-25 |
| WO1998004289A2 (en) | 1998-02-05 |
| AU725817B2 (en) | 2000-10-19 |
| IL128219A0 (en) | 1999-11-30 |
| CA2261813A1 (en) | 1998-02-05 |
| WO1998004289A3 (en) | 1998-03-19 |
| BR9710568A (en) | 1999-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20002787L (en) | New connections | |
| ATE231872T1 (en) | THIAZOLOPYRIMIDE DERIVATIVES | |
| TR200101859T2 (en) | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity | |
| BR9810712A (en) | Process for the prevention or treatment of itching in a patient | |
| NO963506D0 (en) | 4-Heterocyclyl-substituted quinazoline derivatives, process for their preparation and their use as anti-cancer agents | |
| UA66750C2 (en) | Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors | |
| AU5624699A (en) | Use of 5ht-6 antagonists | |
| ATE302606T1 (en) | N-UREIDOALKYLPIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | |
| TR200100054T2 (en) | Paroxetine methanesulfonate | |
| DK1097173T3 (en) | Use of IL-2 peptides and derivatives thereof as therapeutic agents | |
| NO984290L (en) | Pharmaceutically useful compounds | |
| NO990322L (en) | Pharmaceutical mixture containing a 5HT2c antagonist and a D2 antagonist | |
| BR9705456A (en) | Heterocyclic compounds, aminomethyl process for their preparation and pharmaceutical compositions that contain them. | |
| EE03996B1 (en) | Pharmaceutical compositions, process for their preparation and use | |
| SE9504662D0 (en) | New compounds | |
| NO992298L (en) | Conformationally limited LH-RH analogs, their use and pharmaceutical compositions containing these | |
| DK0763535T3 (en) | Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as central nervous system active compounds | |
| AU580890B2 (en) | P-acylaminobenzamides | |
| BR9606955A (en) | Substituted heterocycloalkenes | |
| BR9812002A (en) | Compounds with anti-first pass effect | |
| NO952483D0 (en) | Sesquiterpenes, their preparation and use as inhibitors affecting gababenzodiazepine receptors | |
| SE9803277D0 (en) | Novel compounds | |
| ATE268768T1 (en) | ANTITHROMBOTIC AGENTS | |
| ITMI922216A1 (en) | NITROBENZOILALANINE, PROCEDURE FOR THEIR PREPARATION, THEIR USE AS THERAPEUTIC AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |